title: MDR-TB has new drug foe after fast-track approval.
authors: Rebecca
authors: R
authors: Voelker
mesh_terms: D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D064687:Diarylquinolines; D017277:Drug Approval; D004348:Drug Labeling; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D009965:Orphan Drug Production; D011804:Quinolines / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000995:Antitubercular Agents; D064687:Diarylquinolines; D011804:Quinolines; C493870:bedaquiline